Sara Cuccurullo, MD, FAAPMR, and Talya Fleming, MD, FAAPMR, of Hackensack Meridian JFK Johnson Rehabilitation Institute, ...
The professor of applied neuroimaging at the University of Edinburgh discusses how emerging genetic and vascular mechanisms are opening new therapeutic avenues beyond traditional risk factor ...
Target selection in MG increasingly depends on understanding where a therapy acts within the autoimmune pathway and which ...
The clinical professor of neurology and pediatrics at The Ohio State University Wexner Medical Center discussed payer step ...
The director of the stroke program at Marcus Neuroscience Institute discussed delays in calling 911 after stroke onset, gaps ...
The professor of applied neuroimaging at the University of Edinburgh discusses emerging imaging, blood-based, and functional biomarkers for tracking cerebral small vessel disease progression and ...
At MSToronto 2026, investigators applied machine learning to health records, retinal scans, and blood samples to flag ...
Changes in health care use emerged 5 to 6 years before the first clinical manifestation of MS, with shifts in encounter ...
The editor-in-chief of the Journal of the American Heart Association discusses what editors prioritize in research manuscripts, common submission mistakes, and strategies for improving publication ...
The 36-month CORE-VNS study findings showed sustained seizure reduction, improved quality of life, and reduced ...
A target trial emulation pooling ACCORD-BP and SPRINT data found calcium channel blocker regimens reduced blood pressure variability without changing cardiovascular outcomes.
Remibrutinib (Novartis), an oral Bruton tyrosine kinase (BTK) inhibitor, reduced annualized relapse rate (ARR) vs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results